Baolingbao Biology Co.,Ltd.

SZSE:002286.SZ

7.46 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 2,401.7552,523.9142,712.7452,764.9772,054.5781,805.171,730.0121,592.9961,377.4241,196.282910.71900.769978.028950.773720.615525.4536.555414.326257.343
Cost of Revenue 2,116.3642,319.3822,399.9322,394.7891,866.4751,537.1251,487.8291,379.511,171.7051,032.024801.875764.043776.735747.675579.629411.652410.33305.046188.805
Gross Profit 285.391204.532312.813370.188188.104268.045242.183213.486205.719164.258108.836136.727201.293203.098140.987113.747126.225109.27968.538
Gross Profit Ratio 0.1190.0810.1150.1340.0920.1480.140.1340.1490.1370.120.1520.2060.2140.1960.2160.2350.2640.266
Reseach & Development Expenses 9.53896.9868.4612.58111.29.1194.5395.02615.7326.25610.94813.1326.55.954.2040000
General & Administrative Expenses 19.0214.29926.71427.58315.27712.88815.6679.45512.5957.7427.7019.41611.7920.9747.84925.11925.61314.99110.067
Selling & Marketing Expenses 15.84717.73736.79433.90931.801114.204111.856102.2796.42989.1162.54857.61367.71473.41443.50421.14419.2916.8589.352
SG&A 34.86732.03663.50861.49247.078127.093127.523111.725109.02496.85170.24967.02879.50494.38851.35246.26344.90431.84919.42
Other Expenses 87.01911.50273.22663.89257.17556.302-2.41-0.8068.9610.8214.55918.3248.6044.6929.03610.5714.0752.7820.024
Operating Expenses 131.424140.524145.194137.966115.453192.513170.674156.873168.314138.656111.516110.836119.243130.86579.49648.78248.62433.78120.283
Operating Income 153.96764.008160.23235.9360.73685.33154.07357.89549.736.75413.93930.68871.11261.25941.54935.74849.01249.45531.319
Operating Income Ratio 0.0640.0250.0590.0850.030.0470.0310.0360.0360.0310.0150.0340.0730.0640.0580.0680.0910.1190.122
Total Other Income Expenses Net -22.8531.107-3.540.807-1.104-39.544-1.574-0.8068.72511.0557.20917.57.245-5.558-7.984-18.648-24.5142.7820.024
Income Before Tax 131.11465.115156.69236.73759.63245.78752.557.08958.42547.80927.35449.01379.71665.95150.58446.31853.08752.23731.343
Income Before Tax Ratio 0.0550.0260.0580.0860.0290.0250.030.0360.0420.040.030.0540.0820.0690.070.0880.0990.1260.122
Income Tax Expense 19.95411.14623.52135.1589.7710.8629.8587.9929.2226.8633.4317.08312.39410.2347.787.0458.3118.9411.336
Net Income 111.1653.969133.169201.57949.86235.23442.95349.62249.34340.94623.92241.93167.32655.72242.80539.27444.77733.29620.008
Net Income Ratio 0.0460.0210.0490.0730.0240.020.0250.0310.0360.0340.0260.0470.0690.0590.0590.0750.0830.080.078
EPS 0.30.150.360.550.140.0950.120.130.130.110.060.120.260.210.160.230.220.190.2
EPS Diluted 0.30.150.360.550.140.0950.120.130.130.110.060.120.260.210.160.230.220.190.2
EBITDA 263.698218.499292.35367.329174.677174.521166.149136.55135.306105.35174.566107.995135.248117.2297.808105.465106.15391.39858.993
EBITDA Ratio 0.110.0870.1080.1330.0850.0970.0960.0860.0980.0880.0820.120.1380.1230.1360.2010.1980.2210.229